Noel has active investments in a number of biotech and cleantech companies and currently sit on the boards of Creatus Bio, Arius Technologies, Bast Fibre Technologies, and Incisive Genetics.
Mr. Hall brings extensive experience in the technology, biotechnology, and cleantech sectors, with particular expertise in deal-making, strategic planning, and market development and commercialization. Known as a visionary who sees a clear path to success, Mr. Hall has proven the ability to drive research-based technology into profitable commercialization.
As a serial entrepreneur, Mr. Hall was co-founder and president of Aspreva Pharmaceuticals, taking the company from start-up to profitability and over a billion-dollar market cap in seven years. He is also the co-founder and board chair of Creatus Biosciences, co-founder and board chair of Vitaeris Bio, co-founder and board director of Arius Technology, and former board director for Zymeworks.
Mr. Hall is currently co-director of Machall Investments, a family office focused on the Healthcare, Technology, and cleantech sectors with a particular interest in sustainability.